This PDF is the current document as it appeared on Public Inspection on 11/28/2016 at 08:45 am.
Food and Drug Administration, HHS.
The Food and Drug Administration (FDA) is announcing that a collection of information entitled “Abbreviated New Drug Applications and 505(b)(2) Applications” has been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995.Start Further Info
FOR FURTHER INFORMATION CONTACT:
FDA PRA Staff, Office of Operations, Food and Drug Administration, Three White Flint North, 10A-12M, 11601 Landsdown St., North Bethesda, MD 20852, PRAStaff@fda.hhs.gov.End Further Info End Preamble Start Supplemental Information
On October 6, 2016, the Agency submitted a proposed collection of information entitled “Abbreviated New Drug Applications and 505(b)(2) Applications” to OMB for review and clearance under 44 U.S.C. 3507. An Agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. OMB has now approved the information collection and has assigned OMB control number 0910-0786. The approval expires on November 30, 2019. A copy of the supporting statement for this information collection is available on the Internet at http://www.reginfo.gov/public/do/PRAMain.Start Signature
Dated: November 22, 2016.
Associate Commissioner for Policy.
[FR Doc. 2016-28655 Filed 11-28-16; 8:45 am]
BILLING CODE 4164-01-P